Therefore, to determine if targeting these epigenetic regulators will have an effect on BRAF-mutant melanoma growth, we conducted a chemical genetics screen using the Structural Genome Consortium’s epigenetic chemical probe library, containing 32 small molecule inhibitors targeting proteins encoding epigenetic regulators (Table S1). The gene discussed is BRAF; the disease is melanoma.